<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Gene expression mapping using microarray analysis has identified useful gene signatures for predicting outcome </plain></SENT>
<SENT sid="1" pm="."><plain>However, little of this has been translated into clinically effective diagnostic tools as microarrays require high quality fresh-frozen tissue samples </plain></SENT>
<SENT sid="2" pm="."><plain>We describe a methodology of multiplexed in situ hybridization (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ISH</z:e>) using a novel combination of <z:chebi fb="0" ids="50853">quantum dot</z:chebi> (QD)-labeled oligonucleotide probes and spectral imaging analysis in routinely processed, formalin-fixed paraffin embedded human biopsies </plain></SENT>
<SENT sid="3" pm="."><plain>The conditions for QD-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ISH</z:e> were optimized using a poly d(T) oligonucleotide in decalcified bone marrow samples </plain></SENT>
<SENT sid="4" pm="."><plain>Single and multiplex QD-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ISH</z:e> was performed in samples with <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> and follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> using oligonucleotide probes for myeloperoxidase, bcl-2, survivin, and XIAP </plain></SENT>
<SENT sid="5" pm="."><plain>Spectral imaging was used for post hybridization tissue analysis, enabling separation of spatially colocalized signals </plain></SENT>
<SENT sid="6" pm="."><plain>The method allows quantitative characterization of multiple gene expression using non-bleaching <z:chebi fb="0" ids="51217">fluorochromes</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>This is expected to facilitate multiplex in situ transcript detection in routinely processed human clinical tissue </plain></SENT>
</text></document>